等待開盤 08-01 09:30:00 美东时间
-0.170
-0.19%
今日重点评级关注:古根海姆:维持ProMIS Neurosciences"买入"评级,目标价从35美元升至69美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从38美元升至39美元
07-30 11:45
Citigroup analyst Atif Malik maintains Qorvo (NASDAQ:QRVO) with a Neutral and lowers the price target from $100 to $95.
07-29 21:56
华盛资讯7月29日讯,Qorvo公布2026财年Q2业绩,公司Q2营收7.85亿美元,同比下降4.2%,归母净利润0.86亿美元,同比增长230.8%。
07-29 06:22
华盛资讯7月29日讯,Qorvo公布2026财年Q2业绩,公司Q2营收7.85亿美元,同比下降4.2%,归母净利润0.86亿美元,同比增长235.2%。
07-29 06:10
Skyworks Solutions, Inc. (Nasdaq: SWKS) and Qorvo, Inc. (NASDAQ:QRVO) today announced the expected executive leadership team for the combined company, effective upon the successful completion of the pending transaction. The following executives are expected to report to Mr. Brace as of the closing: ...
07-29 04:10
Qorvo (NASDAQ:QRVO) affirms FY2027 Adj EPS guidance from $7.00 to $7.00 vs $6.83 analyst estimate..
07-29 04:03
Skyworks and Qorvo have announced their expected executive leadership team for the combined company, effective upon completion of their pending merger. Phil Brace will continue as CEO, with key executives including Philip Carter as CFO, Reza Kasnavi as Chief Operations and Technology Officer, and others leading various business units. Bob Bruggeworth, Qorvo's CEO, will join the board post-merger. The leadership team aims to leverage the strengths...
07-28 20:01
Skyworks Solutions (SWKS) snapped six straight sessions of gains on Thursday as its shares declined more than 4%. It ended 4.26% lower at $60.47 during afternoon trading. This likely comes as investor...
07-24 04:48